{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:03:14Z","timestamp":1788454994627,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Postdoctoral Fellowship Program of China Postdoctoral Science Foundation","award":["GZC20240064"],"award-info":[{"award-number":["GZC20240064"]}]},{"name":"Beijing Natural Science Foundation Youth Science Fund Project","award":["7254447"],"award-info":[{"award-number":["7254447"]}]},{"name":"Key Program of the National Natural Science Foundation of China","award":["82330107"],"award-info":[{"award-number":["82330107"]}]},{"name":"Funds for International Cooperation and Exchange of the National Natural Science Foundation of China","award":["7231101396"],"award-info":[{"award-number":["7231101396"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-035024"],"award-info":[{"award-number":["INV-035024"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071426"],"award-info":[{"award-number":["82071426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Young Scientists Fund of the National Natural Science Foundation of China","award":["82204175"],"award-info":[{"award-number":["82204175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The global burden of Guillain-Barr\u00e9 syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the COVID-19 pandemic. We analyzed age-standardized years lived with disability (YLD) for GBS from 1990 to 2021 using GBD 2021 data and COVID-19 vaccination coverage from Our World in Data, focusing on 2020\u20132021. During the pandemic, GBS YLD rates rose dramatically, with greater increases seen in low-SDI regions, females and individuals aged 15\u201329 years. Higher vaccination coverage was inversely associated with GBS disability burden, exhibiting a non-linear protective effect at moderate to high coverage levels. Causal mediation analysis indicated that 44.6% of this association was mediated by reductions in COVID-19 incidence, highlighting both direct and indirect neuroprotective benefits of vaccination programs. These results underscore the importance of sustaining and expanding the vaccine rollout to mitigate the secondary neurological burden associated with emerging infections.<\/jats:p>","DOI":"10.1038\/s41541-025-01239-1","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T15:32:11Z","timestamp":1754148731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"X\u012bn","family":"G\u00e0o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhike","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila, N., Lehmann, H. C. & Kuwabara, S. Guillain-Barr\u00e9 syndrome. Lancet 397, 1214\u20131228 (2021).","journal-title":"Lancet"},{"key":"1239_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/jnnp-2018-317968","volume":"89","author":"B van den Berg","year":"2018","unstructured":"van den Berg, B., Storm, E. F., Garssen, M. J. P., Blomkwist-Markens, P. H. & Jacobs, B. C. Clinical outcome of Guillain-Barr\u00e9 syndrome after prolonged mechanical ventilation. J. Neurol. Neurosurg. Psychiatry 89, 949\u2013954 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1239_CR3","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1212\/WNL.0000000000200885","volume":"99","author":"SE Leonhard","year":"2022","unstructured":"Leonhard, S. E. et al. An International Perspective on Preceding Infections in Guillain-Barr\u00e9 Syndrome: The IGOS-1000 Cohort. Neurology 99, e1299\u2013e1313 (2022).","journal-title":"Neurology"},{"key":"1239_CR4","doi-asserted-by":"publisher","first-page":"e0007622","DOI":"10.1371\/journal.pntd.0007622","volume":"13","author":"A Capasso","year":"2019","unstructured":"Capasso, A., Ompad, D. C., Vieira, D. L., Wilder-Smith, A. & Tozan, Y. Incidence of Guillain-Barr\u00e9 Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis. PLoS. Negl. Trop. Dis. 13, e0007622 (2019).","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"1239_CR5","doi-asserted-by":"publisher","first-page":"e068373","DOI":"10.1136\/bmj-2021-068373","volume":"376","author":"X Li","year":"2022","unstructured":"Li, X. et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ 376, e068373 (2022).","journal-title":"BMJ"},{"key":"1239_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","volume":"9","author":"M Taquet","year":"2022","unstructured":"Taquet, M. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1\u2008284\u2008437 patients. Lancet Psychiatry 9, 815\u2013827 (2022).","journal-title":"Lancet Psychiatry"},{"key":"1239_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson, O. J. et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 22, 1293\u20131302 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1239_CR8","doi-asserted-by":"publisher","first-page":"e2253845","DOI":"10.1001\/jamanetworkopen.2022.53845","volume":"6","author":"WE Abara","year":"2023","unstructured":"Abara, W. E. et al. Reports of Guillain-Barr\u00e9 Syndrome After COVID-19 Vaccination in the United States. Jama. Netw. Open. 6, e2253845 (2023).","journal-title":"Jama. Netw. Open."},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00415-024-12186-7","volume":"271","author":"S Censi","year":"2024","unstructured":"Censi, S., Bisaccia, G., Gallina, S., Tomassini, V. & Uncini, A. Guillain-Barr\u00e9 syndrome and COVID-19 vaccination: a systematic review and meta-analysis. J. Neurol. 271, 1063\u20131071 (2024).","journal-title":"J. Neurol."},{"key":"1239_CR10","doi-asserted-by":"crossref","first-page":"e2094","DOI":"10.1212\/WNL.0000000000207847","volume":"101","author":"S Le Vu","year":"2023","unstructured":"Le Vu, S. et al. Risk of Guillain-Barr\u00e9 Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study. Neurology 101, e2094\u2013e2102 (2023).","journal-title":"Neurology"},{"key":"1239_CR11","doi-asserted-by":"publisher","first-page":"2200744","DOI":"10.2807\/1560-7917.ES.2023.28.24.2200744","volume":"28","author":"HC Lehmann","year":"2023","unstructured":"Lehmann, H. C., Oberle, D., Keller-Stanislawski, B., Rieck, T. & Streit, R. Rare cases of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021. Eur. Surveill. 28, 2200744 (2023).","journal-title":"Eur. Surveill."},{"key":"1239_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"1239_CR13","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144\u20132153 (2021).","journal-title":"Nat. Med."},{"key":"1239_CR14","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","volume":"101","author":"H Bishara","year":"2023","unstructured":"Bishara, H. et al. Association Between Guillain-Barr\u00e9 Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study. Neurology 101, e2035\u2013e2042 (2023).","journal-title":"Neurology"},{"key":"1239_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.875","volume":"11","author":"M Malekpour","year":"2023","unstructured":"Malekpour, M. et al. COVID-19 as a trigger of Guillain-Barr\u00e9 syndrome: A review of the molecular mechanism. Immun. Inflamm. Dis. 11, e875. https:\/\/doi.org\/10.1002\/iid3.875 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"1239_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","volume":"144","author":"S Keddie","year":"2021","unstructured":"Keddie, S. et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain 144, 682\u2013693 (2021).","journal-title":"Brain"},{"key":"1239_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527726","volume":"57","author":"B Hafsteinsd\u00f3ttir","year":"2023","unstructured":"Hafsteinsd\u00f3ttir, B., Dalemo, E., El\u00edasd\u00f3ttir, \u00d3, \u00d3lafsson, E. & Axelsson, M. Decreased Incidence of Guillain-Barr\u00e9 Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study. Neuroepidemiology 57, 1\u20136 (2023).","journal-title":"Neuroepidemiology"},{"key":"1239_CR18","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/brain\/awab279","volume":"144","author":"LWG Luijten","year":"2021","unstructured":"Luijten, L. W. G. et al. Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain 144, 3392\u20133404 (2021).","journal-title":"Brain"},{"key":"1239_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16094","volume":"31","author":"S Censi","year":"2024","unstructured":"Censi, S., Bisaccia, G., Gallina, S., Tomassini, V. & Uncini, A. Guillain-Barr\u00e9 syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the \u2018Italian factor\u2019. Eur. J. Neurol. 31, e16094. https:\/\/doi.org\/10.1111\/ene.16094 (2024).","journal-title":"Eur. J. Neurol."},{"key":"1239_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2450","volume":"33","author":"A Zovi","year":"2023","unstructured":"Zovi, A., Ferrara, F., Langella, R., Cavallaro, F. & Vitiello, A. Sex affects immune response capacity against COVID-19 infection. Rev. Med. Virol. 33, e2450. https:\/\/doi.org\/10.1002\/rmv.2450 (2023).","journal-title":"Rev. Med. Virol."},{"key":"1239_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101818","volume":"84","author":"MR Zinatizadeh","year":"2023","unstructured":"Zinatizadeh, M. R. et al. Immunosenescence and inflamm-ageing in COVID-19. Ageing Res. Rev. 84, 101818. https:\/\/doi.org\/10.1016\/j.arr.2022.101818 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1239_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02319-4","volume":"18","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi, N. L. et al. Global, regional, and national burden of Guillain-Barr\u00e9 syndrome and its underlying causes from 1990 to 2019. J. Neuroinflammation. 18, 264 (2021).","journal-title":"J. Neuroinflammation."},{"key":"1239_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41582-021-00467-y","volume":"17","author":"N Papri","year":"2021","unstructured":"Papri, N. et al. Guillain-Barr\u00e9 syndrome in low-income and middle-income countries: challenges and prospects. Nat. Rev. Neurol. 17, 285\u2013296 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1239_CR24","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.05022","volume":"12","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies. J. Glob. Health 12, 05022. https:\/\/doi.org\/10.7189\/jogh.12.05022 (2022).","journal-title":"J. Glob. Health"},{"key":"1239_CR25","doi-asserted-by":"publisher","first-page":"e1372","DOI":"10.1016\/S2214-109X(20)30383-1","volume":"8","author":"T Tan-Torres Edejer","year":"2020","unstructured":"Tan-Torres Edejer, T. et al. Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study. Lancet Glob. Health 8, e1372\u2013e1379 (2020).","journal-title":"Lancet Glob. Health"},{"key":"1239_CR26","doi-asserted-by":"publisher","first-page":"e011881","DOI":"10.1136\/bmjgh-2023-011881","volume":"8","author":"L Privor-Dumm","year":"2023","unstructured":"Privor-Dumm, L. et al. Vaccine access, equity and justice: COVID-19 vaccines and vaccination. Bmj. Glob. Health 8, e011881 (2023).","journal-title":"Bmj. Glob. Health"},{"key":"1239_CR27","doi-asserted-by":"publisher","first-page":"1087138","DOI":"10.3389\/fpubh.2022.1087138","volume":"10","author":"B Duroseau","year":"2022","unstructured":"Duroseau, B., Kipshidze, N. & Limaye, R. J. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries. Front. Public. Health 10, 1087138 (2022).","journal-title":"Front. Public. Health"},{"key":"1239_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s41182-023-00564-2","volume":"51","author":"CR Wei","year":"2023","unstructured":"Wei, C. R., Kamande, S. & Lang\u2019at, G. C. Vaccine inequity: a threat to Africa\u2019s recovery from COVID-19. Trop. Med. Health 51, 69 (2023).","journal-title":"Trop. Med. Health"},{"key":"1239_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0000000000207998","volume":"101","author":"D Bourdette","year":"2023","unstructured":"Bourdette, D. & Silbermann, E. What Are the Risks of Guillain-Barr\u00e9 Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination? Neurology 101, 875\u2013876 (2023).","journal-title":"Neurology"},{"key":"1239_CR30","doi-asserted-by":"publisher","first-page":"e908","DOI":"10.1212\/WNL.0000000000008012","volume":"93","author":"A Hapfelmeier","year":"2019","unstructured":"Hapfelmeier, A., Gasperi, C., Donnachie, E. & Hemmer, B. A large case-control study on vaccination as risk factor for multiple sclerosis. Neurology 93, e908\u2013e916 (2019).","journal-title":"Neurology"},{"key":"1239_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamapsychiatry.2019.3523","volume":"77","author":"S Dalsgaard","year":"2020","unstructured":"Dalsgaard, S. et al. Incidence Rates and Cumulative Incidences of the Full Spectrum of Diagnosed Mental Disorders in Childhood and Adolescence. Jama. Psychiatry 77, 155\u2013164 (2020).","journal-title":"Jama. Psychiatry"},{"key":"1239_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100302","volume":"18","author":"P Zheng","year":"2022","unstructured":"Zheng, P., Tian, D. C., Xiu, Y., Wang, Y. & Shi, F. D. Incidence of Guillain-Barr\u00e9 syndrome (GBS) in China: A national population-based study. Lancet Reg. Health West. Pac. 18, 100302. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100302 (2022).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1239_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1415986","volume":"15","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Variation in worldwide incidence of Guillain-Barr\u00e9 syndrome: a population-based study in urban China and existing global evidence. Front. Immunol. 15, 1415986. https:\/\/doi.org\/10.3389\/fimmu.2024.1415986 (2024).","journal-title":"Front. Immunol."},{"key":"1239_CR34","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Results.). Institute for Health Metrics and Evaluation (IHME) (2022)."},{"key":"1239_CR35","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Socio-Demographic Index (SDI) 1950\u20132021.). Institute for Health Metrics and Evaluation (IHME) (2024)."},{"key":"1239_CR36","unstructured":"Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396, 1250-1284 (2020)."},{"key":"1239_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu, E. et al. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 5, 947\u2013953 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"1239_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","volume":"5","author":"T Hale","year":"2021","unstructured":"Hale, T. et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat. Hum. Behav. 5, 529\u2013538 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"1239_CR39","first-page":"31","volume":"11","author":"BF Hankey","year":"2000","unstructured":"Hankey, B. F. et al. Partitioning linear trends in age-adjusted rates. Cancer Causes. Control. 11, 31\u201335 (2000).","journal-title":"Cancer Causes. Control."},{"key":"1239_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim, H. J., Fay, M. P., Feuer, E. J. & Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19, 335\u2013351 (2000).","journal-title":"Stat. Med."},{"key":"1239_CR41","unstructured":"National Cancer Institute. How Joinpoint Selects the Final Model. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/model-selection-method (accessed June 2024)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01239-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01239-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01239-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:34:06Z","timestamp":1757334846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01239-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01239-1","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}